US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 4.160
  • -0.050-1.19%
Close May 3 16:00 ET
  • 4.090
  • -0.070-1.68%
Post 19:32 ET
247.16MMarket Cap-8156P/E (TTM)

About Aldeyra Therapeutics Company

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Company Profile

SymbolALDX
Company NameAldeyra Therapeutics
Listing DateMay 2, 2014
Issue Price8.00
Founded2004
CEODr. Todd C. Brady, M.D.,PhD
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address131 Hartwell Avenue,Suite 320
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-781-761-4904
Websitehttp://www.aldeyra.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Todd C. Brady, M.D.,PhD
  • Chief Executive Officer, President and Director
  • 3.68M
  • Dr. Stephen G. Machatha
  • Chief Development Officer
  • 1.59M
  • Bruce Greenberg
  • Senior Vice President, Finance, Principal Accounting Officer and Interim Chief Financial Officer
  • 974.07K
  • Dr. Richard H. Douglas, PhD
  • Chairman of the Board
  • 221.98K
  • Martin J. Joyce
  • Independent Director
  • 195.66K
  • Dr. Neal Walker, D.O.
  • Independent Director
  • 174.22K
  • Dr. Gary M. Phillips, M.D.
  • Independent Director
  • 194.07K
  • Dr. Ben Bronstein, M.D.
  • Independent Director
  • 190.40K
  • Nancy Miller-Rich
  • Independent Director
  • 174.22K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg